Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study

CytoSorb(®) (CytoSorbents Corporation, USA) is a novel sorbent hemoadsorption device for cytokine removal. The aim of this study was to examine the clinical use of CytoSorb(®) in the management of patient with septic shock. We used this device as an adjuvant to stabilize a young patient with multi-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Reshma, Pathak, Sunjay, Goyal, Jyoti, Chaudhry, Rajeev, Goel, Rati B., Barwal, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271283/
https://www.ncbi.nlm.nih.gov/pubmed/25538418
http://dx.doi.org/10.4103/0972-5229.146321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271283/
https://www.ncbi.nlm.nih.gov/pubmed/25538418
http://dx.doi.org/10.4103/0972-5229.146321

Ejemplares similares